Publications in collaboration with researchers from Eli Lilly and Company (5)

2022

  1. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

    ACS Pharmacology and Translational Science, Vol. 5, Núm. 11, pp. 1097-1108

2020

  1. Acetylcholinesterase inhibition of diversely functionalized quinolinones for alzheimer’s disease therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 11, pp. 1-20

  2. Automated Synthesis of New Quinoxalinetacrines

    ChemistrySelect, Vol. 5, Núm. 21, pp. 6491-6493

2019

  1. Chromenones as Multineurotargeting Inhibitors of Human Enzymes

    ACS Omega, Vol. 4, Núm. 26, pp. 22161-22168

2004

  1. Synthesis, DNA intercalation and europium(III)-triggered DNA photocleavage by a bis-proflavine succinamide conjugate

    Tetrahedron Letters, Vol. 45, Núm. 21, pp. 4017-4020